technology appraisal
Response to NICE guidance on Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears
Ciclosporin (1mg/ml, Ikervis®) is a sterile, positively charged, oil-in water, unpreserved ophthalmic emulsion for the treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes. It is administered as a once daily eye drop at bed time. The Royal College of Ophthalmologists welcomes the decision